Single dose oral etoricoxib for acute postoperative pain in adults.

Journal article

BACKGROUND: This is an updated version of the original Cochrane review first published in Issue 2, 2009, and updated in Issue 4, 2012.Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor licensed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain in some jurisdictions. This class of drugs is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs). OBJECTIVES: To...

Expand abstract

Authors: Clarke, R; Derry, S; Moore, R

• Publication status: Published
• Journal: Cochrane database of systematic reviews
• Volume: 5
• Issue: 5
• Pages: CD004309
• Publication date: 2014-01-01
• DOI: 10.1002/14651858.cd004309.pub4
• EISSN: 1469-493X
• ISSN: 1469-493X
• Language: English
• Keywords: Humans; Sulfones [administration and dosage; adverse effects]; Randomized Controlled Trials as Topic; Cyclooxygenase 2 Inhibitors [administration and dosage; adverse effects]; Pain, Postoperative [drug therapy]; Administration, Oral; Adult; Pyridines [administration and dosage; adverse effects]